全球乳癌诊断市场

预计到 2030 年全球乳癌诊断市场规模将达 69 亿美元

全球乳癌诊断市场规模预计在2024年为47亿美元，预计到2030年将达到69亿美元，2024年至2030年的复合年增长率为6.4%。成像技术是本报告分析的细分市场之一，预计其复合年增长率为7.3%，到分析期结束时规模将达到30亿美元。活体组织切片细分市场在分析期间内的复合年增长率预计为6.3%。

美国市场规模估计为 13 亿美元，中国市场预计复合年增长率为 10.2%

美国乳癌诊断市场规模预计在2024年达到13亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到14亿美元，在2024-2030年的分析期间内，复合年增长率为10.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.1%和6.3%。在欧洲，预计德国市场的复合年增长率为4.2%。

全球乳癌诊断市场—主要趋势与驱动因素摘要

为什么早期发现乳癌比以往任何时候都重要？

乳癌仍然是世界上最普遍和最危及生命的恶性肿瘤之一，因此早期发现对于提高患者存活率至关重要。乳癌诊断技术的进步大大提高了早期发现乳癌的能力，从而可以及时干预和製定更有效的治疗策略。虽然乳房 X乳房X光摄影、超音波和切片检查等传统诊断方法仍然发挥关键作用，液态切片和人工智慧辅助成像等新兴技术正在迅速改变这一状况。政府支持的宣传宣传活动和定期筛检计画增加了早期发现的频率，从而提高了存活率。此外，数位健康解决方案和远端医疗平台的整合正在扩大诊断服务的覆盖面，特别是在偏远和服务不足的地区。由于早期诊断仍然是有效管理乳癌的关键，预计筛检技术的持续进步将推动市场成长。

乳癌诊断领域有哪些最新创新？

随着最尖端科技的引入，乳癌诊断领域正在不断发展，这些技术提高了准确性并减少了假阳性。人工智慧影像分析、深度学习演算法和机器学习模型提高了乳房X光摄影光检查和超音波解释的准确性，并最大限度地减少了人为错误。液态切片是一种非侵入性诊断技术，透过检测血液样本中的循环肿瘤 DNA (ctDNA) 和肿瘤相关标记物，作为传统组织切片检查的替代方案，逐渐普及。此外，3D 断层合成技术的进步提供了高解析度影像，改善了病灶检测并减少了不必要的切片检查。数位病理学和云端基础的诊断平台也透过实现远距咨询和医疗服务提供者之间的无缝数据共用，彻底改变了乳癌诊断。随着分子和基因检测方法研究的进展，预计这些创新方法将塑造乳癌诊断的未来。

哪些医疗保健领域正在引领乳癌诊断技术的应用？

乳癌诊断工具的应用正在各个医疗领域不断扩展，包括医院、影像中心、病理实验室和乳癌专科诊所。医院仍然是乳癌综合诊断的首要中心，提供一站式一系列影像和切片检查服务。影像中心越来越多地配备最先进的乳房X光乳房X光摄影和核磁共振成像系统，以满足对精准、非侵入性筛检解决方案日益增长的需求。病理实验室也越来越多地采用人工智慧驱动的数位病理工具，以提高组织分析和生物标记检测的效率。此外，行动筛检单元和远端医疗服务在将乳癌诊断服务扩展到农村和服务匮乏的人群方面发挥关键作用。随着世界各地的医疗机构投资下一代诊断工具，乳癌检测的可近性和准确性预计将显着提高。

推动市场成长的因素有哪些？

乳癌诊断市场的成长受到多种因素的推动，包括影像技术的进步、乳癌盛行率的上升以及精准诊断投资的增加。人工智慧诊断工具和液态切片技术的扩展增强了早期检测能力，使更有针对性的治疗方法成为可能。政府推动乳癌筛检计划的措施和不断增长的医疗保健支出进一步推动了市场需求。此外，数位健康平台、穿戴式乳癌检测设备和云端基础的诊断解决方案的整合简化了患者监测和数据分析。製药和生物技术公司正在积极与研究机构合作，开发基于生物标记的诊断测试，以提高乳癌检测的准确性。随着技术的进步，乳癌诊断市场正在经历持续成长，为早期有效的疾病管理提供了新的可能性。

部分

类型（成像技术、切片检查、基因组检测、血液检测、其他类型）、产品类型（基于仪器的产品、基于平台的产品）、应用（诊断/预测应用、筛检应用、预后应用、研究应用）、最终用途（医院/诊所最终用途、诊断中心/医学实验室最终用途、其他最终用途）

受访公司范例

• AstraZeneca PLC
• Becton, Dickinson and Company
• Danaher Corporation
• Devicor Medical Products Inc.
• Exact Sciences Corporation
• F. Hoffmann-La Roche Ltd.（Roche Diagnostics）
• GE HealthCare
• Hologic, Inc.
• Ibex Medical Analytics Ltd.
• Koninklijke Philips NV
• NanoString Technologies, Inc.
• Quest Diagnostics Incorporated
• Siemens Healthineers AG

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Breast Cancer Diagnostics Market to Reach US$6.9 Billion by 2030

The global market for Breast Cancer Diagnostics estimated at US$4.7 Billion in the year 2024, is expected to reach US$6.9 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Imaging Techniques, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$3.0 Billion by the end of the analysis period. Growth in the Biopsy segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 10.2% CAGR

The Breast Cancer Diagnostics market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 10.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Breast Cancer Diagnostics Market - Key Trends & Drivers Summarized

Why Is Early Breast Cancer Detection More Important Than Ever?

Breast cancer remains one of the most prevalent and life-threatening malignancies worldwide, making early detection crucial in improving patient survival rates. Advances in breast cancer diagnostics have significantly enhanced the ability to identify the disease at its earliest stages, allowing for timely interventions and more effective treatment strategies. Traditional diagnostic methods, including mammography, ultrasound, and biopsy, continue to play a pivotal role, but emerging techniques such as liquid biopsies and AI-assisted imaging are rapidly transforming the landscape. Government-backed awareness campaigns and routine screening programs have increased the frequency of early detection, leading to improved survival outcomes. Additionally, the integration of digital health solutions and telemedicine platforms is expanding access to diagnostic services, particularly in remote and underserved regions. As early diagnosis remains the cornerstone of effective breast cancer management, continued advancements in screening technologies are expected to drive market growth.

What Are the Latest Innovations in Breast Cancer Diagnostics?

The field of breast cancer diagnostics is evolving with the introduction of cutting-edge technologies that improve accuracy and reduce false positives. AI-powered imaging analysis, deep-learning algorithms, and machine-learning models are enhancing the precision of mammography and ultrasound interpretations, minimizing human error. Liquid biopsy, a non-invasive diagnostic technique, is gaining traction as an alternative to traditional tissue biopsies by detecting circulating tumor DNA (ctDNA) and tumor-associated markers in blood samples. Furthermore, advancements in 3D tomosynthesis provide high-resolution imaging, improving lesion detection and reducing unnecessary biopsies. Digital pathology and cloud-based diagnostic platforms are also revolutionizing breast cancer diagnostics by enabling remote consultations and seamless data sharing among healthcare providers. As research continues to refine molecular and genetic testing methodologies, these innovative approaches are expected to shape the future of breast cancer diagnostics.

Which Healthcare Sectors Are Leading the Adoption of Breast Cancer Diagnostic Technologies?

The adoption of breast cancer diagnostic tools is widespread across various healthcare sectors, including hospitals, diagnostic imaging centers, pathology laboratories, and specialized breast cancer clinics. Hospitals continue to serve as primary centers for comprehensive breast cancer diagnostics, offering a range of imaging and biopsy procedures under one roof. Diagnostic imaging centers are increasingly equipping themselves with state-of-the-art mammography and MRI systems, catering to the growing demand for precise and non-invasive screening solutions. Pathology laboratories are integrating AI-driven digital pathology tools to enhance the efficiency of tissue analysis and biomarker testing. Moreover, mobile screening units and telehealth services are playing a vital role in extending breast cancer diagnostic services to rural and underserved populations. As healthcare facilities worldwide invest in next-generation diagnostic tools, the accessibility and accuracy of breast cancer detection are expected to improve significantly.

What Factors Are Driving Market Growth?

The growth in the breast cancer diagnostics market is driven by several factors, including advancements in imaging technologies, the increasing prevalence of breast cancer, and rising investments in precision diagnostics. The expansion of AI-powered diagnostic tools and liquid biopsy techniques is enhancing early detection capabilities, allowing for more targeted treatment approaches. Government initiatives promoting breast cancer screening programs and increased healthcare expenditure are further fueling market demand. Additionally, the integration of digital health platforms, wearable breast cancer detection devices, and cloud-based diagnostic solutions is streamlining patient monitoring and data analysis. Pharmaceutical and biotech companies are actively collaborating with research institutions to develop biomarker-based diagnostic tests, improving the accuracy of breast cancer detection. As technology continues to advance, the breast cancer diagnostics market is poised for sustained growth, offering new possibilities for early and more effective disease management.

SCOPE OF STUDY:

The report analyzes the Breast Cancer Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Imaging Techniques, Biopsy, Genomic Tests, Blood Tests, Other Types); Product Type (Instrument-based Products, Platform-based Products); Application (Diagnostic and Predictive Application, Screening Application, Prognostic Application, Research Application); End-Use (Hospitals and Clinics End-Use, Diagnostic Centers and Medical Laboratories End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• AstraZeneca PLC
• Becton, Dickinson and Company
• Danaher Corporation
• Devicor Medical Products Inc.
• Exact Sciences Corporation
• F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
• GE HealthCare
• Hologic, Inc.
• Ibex Medical Analytics Ltd.
• Koninklijke Philips N.V.
• NanoString Technologies, Inc.
• Quest Diagnostics Incorporated
• Siemens Healthineers AG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Breast Cancer Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Incidence of Breast Cancer Propels Demand for Early and Accurate Diagnostic Solutions
  • Technological Advancements in Imaging Modalities Strengthen Business Case for Advanced Diagnostics
  • Increased Adoption of Molecular and Genetic Testing Expands Scope for Personalized Diagnostics
  • Integration of Artificial Intelligence in Radiology Spurs Accuracy and Efficiency in Breast Cancer Detection
  • Government-Sponsored Screening Programs Drive Mass Adoption of Diagnostic Tools
  • Growing Awareness and Patient Education Campaigns Accelerate Demand for Preventive Diagnostics
  • Expansion of Point-of-Care and Mobile Diagnostic Units Expands Accessibility in Underserved Regions
  • Regulatory Approvals and Reimbursement Support Propel Adoption of Innovative Diagnostic Technologies
  • Rise in Demand for Non-Invasive and Minimally Invasive Diagnostic Methods Spurs Technology Innovation
  • Integration of Digital Pathology and Cloud-Based Data Management Drives Diagnostic Workflow Optimization
  • Challenges in False Positives and Overdiagnosis Drive Demand for More Specific Biomarkers
  • Clinical Adoption of Liquid Biopsy and Circulating Tumor DNA Testing Expands Diagnostic Market Potential
  • Global Expansion of Diagnostic Imaging Centers Sustains Growth in Equipment and Consumables Demand
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Breast Cancer Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Breast Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Breast Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Imaging Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Imaging Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Imaging Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Genomic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Genomic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Genomic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Blood Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Blood Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Blood Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Prognostic Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Prognostic Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Prognostic Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic & Predictive Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Diagnostic & Predictive Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Diagnostic & Predictive Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Screening Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Screening Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Screening Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Diagnostic Centers & Medical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Diagnostic Centers & Medical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Diagnostic Centers & Medical Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Instrument-based Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Instrument-based Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Instrument-based Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Platform-based Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Platform-based Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Platform-based Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Breast Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Canada 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• JAPAN
  • Breast Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Japan 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• CHINA
  • Breast Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 83: China Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: China 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• EUROPE
  • Breast Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Breast Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Breast Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Europe 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• FRANCE
  • Breast Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 110: France Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: France 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: France 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• GERMANY
  • Breast Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Germany 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Germany 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Italy 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Italy 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Breast Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 146: UK Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: UK 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: UK 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Spain 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Spain 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Russia 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Russia 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Breast Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Breast Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Breast Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Breast Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Australia 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Australia 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• INDIA
  • Breast Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 221: India Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: India 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: India 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: South Korea 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: South Korea 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Breast Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Breast Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Breast Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Latin America 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Latin America 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Argentina 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Argentina 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Brazil 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Brazil 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Mexico 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Mexico 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Breast Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Breast Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Breast Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Middle East 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Middle East 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Iran 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Iran 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Israel 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Israel 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: UAE 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: UAE 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030
• AFRICA
  • Breast Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Breast Cancer Diagnostics by Type - Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Breast Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging Techniques, Biopsy, Genomic Tests, Blood Tests and Other Types for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Breast Cancer Diagnostics by Application - Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Breast Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Prognostic Application, Research Application, Diagnostic & Predictive Application and Screening Application for the Years 2015, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Breast Cancer Diagnostics by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Africa 15-Year Perspective for Breast Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers & Medical Laboratories End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Breast Cancer Diagnostics by Product Type - Instrument-based Products and Platform-based Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Africa 15-Year Perspective for Breast Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instrument-based Products and Platform-based Products for the Years 2015, 2025 & 2030

IV. COMPETITION